Business Wire

Bynder Kicks Off Peak Shopping Season by Serving a Record 6 Billion Assets - Powering Exceptional Global Content Experiences Online

Share

Bynder, a global leader in AI-powered enterprise DAM, has helped a number of global brands break Black Friday and Cyber Monday records by delivering exceptional content experiences at scale across a number of worldwide e-commerce channels.

During the seven day period (November 27 - Dec 2 2024) which included Black Friday, Small Business Saturday, and Cyber Monday, Bynder’s Content Experiences (CX) for Omnichannel solution was responsible for serving more than 6 billion assets to over 70,000 websites, with more than 4.5 billion asset transformations undertaken.

The figures represent a 15% increase in assets delivered vs 2023, plus 67% more assets were delivered through CX for Omnichannel on Black Friday than an average day in 2024.

Customers such as Sur La Table, Bose, Raymour & Flanigan and Puma used CX for Omnichannel to deliver targeted and optimized content at scale to their digital channels over the busiest shopping days. Bynder customers were able to utilize the assets stored in their Bynder DAM and transform and deliver them to their digital channels, including their website, e-commerce sites, emails and social media.

Bynder’s DAM sits at the heart of a brand’s martech stack as the system of record for digital assets, while Bynder’s CX for Omnichannel solution is the delivery technology that connects the DAM to a brand’s tech ecosystem and automates delivering optimized assets for each digital channel in real time.

For consumer brands that are delivering seasonal shopping content across a number of e-commerce platforms, Bynder’s solution can transform, optimize and deliver targeted content experiences based on the channel and audience automatically, that boost return on investment all while ensuring brand consistency, improved website performance and increase in conversions for e-commerce sites.

According to a NielsenIQ study analyzed by Barcelona's OBS Business School, Black Friday has become one of the most anticipated European retail periods in the run-up to the holiday season, with 61% of consumers in Spain, the UK, Italy, France, and Germany expected to have participated in Black Friday. While in the US, a record 200.4 million consumers shopped over the five-day holiday weekend from Thanksgiving Day through Cyber Monday, surpassing last year’s record of 196.7 million.

When creating and managing seasonal assets, a survey by Bynder revealed that 51% of marketers agreed that more marketing assets are required for Black Friday than any other seasonal holiday. The biggest challenge stated for just over one in three (36%) respondents was managing the number of assets they were creating for the peak shopping season.

Sur La Table, a retailer known for a variety of upscale cooking and dining supplies, is one such brand scaling its content delivery through Bynder during the holiday peak period.

Blake Bakanoff, VP of Creative at Sur La Table, said, “A good tool improves the way we work. A great partner improves the way we think, make and move.At Sur La Table, bringing value to our customers, by creating exceptional culinary content, lies at the core of our brand. We’re “Makers” at heart, and Bynder’s CX for Omnichannel solution empowers us to create, adapt, and deliver a wealth of custom content tailored to every channel—whether it’s showcasing thoughtful gift ideas on Instagram, sharing original holiday recipes through email, or engaging customers as they explore our website. By connecting our teams and external partners to our extensive content catalog delivering 165M+ assets, Bynder enables us to inspire and delight our customers with curated, memorable experiences during the peak holiday season."

Peter-Paul Houtman, CTO at Bynder, said: “The period between Thanksgiving and Cyber Monday represents some of the busiest days for e-commerce retailers. The volume of shoppers has increased over time and so has the volume of products that are available at a discount. E-commerce retailers are dealing with a higher volume of transactions and they need a scalable AI-powered enterprise grade platform like Bynder’s DAM, as well as its Content Experiences (CX) for Omnichannel solution, to deliver exceptional content experiences for their customers during these peak times.

“A unified omnichannel approach in terms of managing assets and delivering assets digitally ensures no opportunity is missed during peak retail seasons and by using Content Experiences for Omnichannel, leading brands can supercharge their marketing strategies and boost engagement by creating targeted content experiences across a number of digital touchpoints, improving website performance and conversions to bring real return-on-investment to businesses.”

For more information on Bynder’s DAM, please visit: https://www.bynder.com/en/products/digital-asset-management/ and for more information on Content Experiences (CX) for Omnichannel, please visit: https://www.bynder.com/en/products/content-experiences-for-omnichannel/

View source version on businesswire.com: https://www.businesswire.com/news/home/20241209828157/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye